140 related articles for article (PubMed ID: 26458093)
1. Histopathology of melanocytic lesions in a family with an inherited BAP1 mutation.
O'Shea SJ; Mitra A; Graham JL; Charlton R; Adlard J; Merchant W; Newton-Bishop JA
J Cutan Pathol; 2016 Mar; 43(3):287-9. PubMed ID: 26458093
[No Abstract] [Full Text] [Related]
2. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
3. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature.
Wysozan TR; Khelifa S; Turchan K; Alomari AK
J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
Webster JD; Pham TH; Wu X; Hughes NW; Li Z; Totpal K; Lee HJ; Calses PC; Chaurushiya MS; Stawiski EW; Modrusan Z; Chang MT; Tran C; Lee WP; Chalasani S; Hung J; Sharma N; Chan S; Hotzel K; Talevich E; Shain A; Xu M; Lill J; Dixit VM; Bastian BC; Dey A
Pigment Cell Melanoma Res; 2019 Mar; 32(2):269-279. PubMed ID: 30156010
[TBL] [Abstract][Full Text] [Related]
5. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes.
Busam KJ; Sung J; Wiesner T; von Deimling A; Jungbluth A
Am J Surg Pathol; 2013 Feb; 37(2):193-9. PubMed ID: 23026932
[TBL] [Abstract][Full Text] [Related]
6. BAP1-inactivated melanocytic tumor with preserved BAP1 expression? Morphology to the rescue!
Duncan LM; Tetzlaff MT
J Cutan Pathol; 2020 May; 47(5):459-461. PubMed ID: 32096236
[TBL] [Abstract][Full Text] [Related]
7. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
[TBL] [Abstract][Full Text] [Related]
8. PReferentially expressed antigen in MElanoma (PRAME) expression in BRCA1-associated protein (BAP1)-inactivated melanocytic tumors and deep penetrating nevi: A pilot study.
Lopez DR; Forcucci JA; O'Connor H; Maize JC
J Cutan Pathol; 2021 Apr; 48(4):597-600. PubMed ID: 33094849
[No Abstract] [Full Text] [Related]
9. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.
Zhang AJ; Rush PS; Tsao H; Duncan LM
J Cutan Pathol; 2019 Dec; 46(12):965-972. PubMed ID: 31233225
[TBL] [Abstract][Full Text] [Related]
10. BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature.
Donati M; Šteiner P; Kazakov DV
Am J Dermatopathol; 2023 Feb; 45(2):117-122. PubMed ID: 36669076
[TBL] [Abstract][Full Text] [Related]
11. BAP1-inactivated melanocytic tumour with borderline histopathological features (BAP1-inactivated melanocytoma): A case report and a reappraisal.
Ferrara G; Mariani MP; Auriemma M
Australas J Dermatol; 2021 Feb; 62(1):e88-e91. PubMed ID: 33107024
[TBL] [Abstract][Full Text] [Related]
12. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome.
Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N
Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346
[TBL] [Abstract][Full Text] [Related]
13. BAP1-deficient and VE1-negative atypical Spitz tumor.
Requena C; Sanz V; Nagore E; García-Casado Z; Rubio L; Guillén C; Kutzner H
J Cutan Pathol; 2015 Aug; 42(8):564-7. PubMed ID: 25953246
[TBL] [Abstract][Full Text] [Related]
14. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.
Matatall KA; Agapova OA; Onken MD; Worley LA; Bowcock AM; Harbour JW
BMC Cancer; 2013 Aug; 13():371. PubMed ID: 23915344
[TBL] [Abstract][Full Text] [Related]
15. Unpigmented nodule with loss of BAP1 expression in a medium-sized congenital nevus.
Rocas D; Castillo C; Lamarca S; Gallateau-Salle F; Paindavoine S; Pissaloux D; De La Fouchardiere A
Eur J Dermatol; 2015 Apr; 25(2):201-2. PubMed ID: 25652719
[No Abstract] [Full Text] [Related]
16. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome.
Busam KJ; Wanna M; Wiesner T
JAMA Dermatol; 2013 Mar; 149(3):335-9. PubMed ID: 23552620
[TBL] [Abstract][Full Text] [Related]
17. Dermoscopy of BAP1-inactivated melanocytic tumours.
Buljan M; Marušić Z; Franceschi N
Australas J Dermatol; 2022 Feb; 63(1):86-90. PubMed ID: 34398452
[No Abstract] [Full Text] [Related]
18. Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma.
Sargen MR; Cloutier JM; Sarin KY; Rieger KE; Chu P; Swetter SM; Novoa RA
Pigment Cell Melanoma Res; 2019 May; 32(3):474-478. PubMed ID: 30672662
[No Abstract] [Full Text] [Related]
19. BAP1 has a survival role in cutaneous melanoma.
Kumar R; Taylor M; Miao B; Ji Z; Njauw JC; Jönsson G; Frederick DT; Tsao H
J Invest Dermatol; 2015 Apr; 135(4):1089-1097. PubMed ID: 25521456
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous melanocytic tumors. Case 1].
de la Fouchardière A
Ann Pathol; 2016 Oct; 36(5):317-321. PubMed ID: 27641817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
